Targeted Medical Pharma, Inc.
TRGM · OTC
12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $0 | $0 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $1 | $0 |
| Other Curr. Assets | $0 | $0 | $1 | $1 |
| Total Curr. Assets | $1 | $1 | $3 | $3 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $2 | $2 | $2 | $2 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $5 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $2 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2 | $3 | $5 | $11 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $1 | $2 |
| Short-Term Debt | $5 | $4 | $4 | $5 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $7 | $6 | $5 |
| Total Curr. Liab. | $15 | $12 | $11 | $12 |
| LT Debt | $1 | $0 | $1 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $1 |
| Other NC Liab. | $0 | $0 | $0 | -$1 |
| Total NC Liab. | $1 | $0 | $1 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $15 | $12 | $12 | $13 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$30 | -$27 | -$23 | -$14 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $17 | $17 | $16 | $12 |
| Total Equity | -$13 | -$10 | -$7 | -$2 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2 | $3 | $5 | $11 |
| Net Debt | $5 | $4 | $4 | $5 |